232 related articles for article (PubMed ID: 28507113)
1. Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B.
Velásquez AMA; Ribeiro WC; Venn V; Castelli S; Camargo MS; de Assis RP; de Souza RA; Ribeiro AR; Passalacqua TG; da Rosa JA; Baviera AM; Mauro AE; Desideri A; Almeida-Amaral EE; Graminha MAS
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507113
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
3. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Antileishmanial Activity of Thioridazine.
Sifontes-Rodríguez S; Mollineda-Diogo N; Monzote-Fidalgo L; Escalona-Montaño AR; Escario García-Trevijano JA; Aguirre-García MM; Meneses-Marcel A
Acta Parasitol; 2024 Mar; 69(1):324-331. PubMed ID: 38070122
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
[TBL] [Abstract][Full Text] [Related]
7. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles Loaded with a New Thiourea Derivative: Development and
Meireles PW; de Souza DPB; Rezende MG; Borsodi MPG; de Oliveira DE; da Silva LCRP; de Souza AMT; Viana GM; Rodrigues CR; do Carmo FA; de Sousa VP; Rossi-Bergmann B; Cabral LM
Curr Drug Deliv; 2020; 17(8):694-702. PubMed ID: 32621717
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate.
Ferreira BA; Coser EM; de la Roca S; Aoki JI; Branco N; Soares GHC; Lima MIS; Coelho AC
PLoS Negl Trop Dis; 2024 May; 18(5):e0012175. PubMed ID: 38768213
[TBL] [Abstract][Full Text] [Related]
11. New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in
Velásquez AMA; Bartlett PJ; Linares IAP; Passalacqua TG; Teodoro DDL; Imamura KB; Virgilio S; Tosi LRO; Leite AL; Buzalaf MAR; Velasques JM; Netto AVG; Thomas AP; Graminha MAS
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0076721. PubMed ID: 34633848
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
Wijnant GJ; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607026
[TBL] [Abstract][Full Text] [Related]
13. A lupane-triterpene isolated from Combretum leprosum Mart. fruit extracts that interferes with the intracellular development of Leishmania (L.) amazonensis in vitro.
Teles CB; Moreira-Dill LS; Silva Ade A; Facundo VA; de Azevedo WF; da Silva LH; Motta MC; Stábeli RG; Silva-Jardim I
BMC Complement Altern Med; 2015 Jun; 15():165. PubMed ID: 26048712
[TBL] [Abstract][Full Text] [Related]
14. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
15. Leishmanicidal Activity of Isoselenocyanate Derivatives.
Fernández-Rubio C; Larrea E; Peña Guerrero J; Sesma Herrero E; Gamboa I; Berrio C; Plano D; Amin S; Sharma AK; Nguewa PA
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478164
[TBL] [Abstract][Full Text] [Related]
16. N
Present C; Girão RD; Lin C; Caljon G; Van Calenbergh S; Moreira O; Ruivo LAS; Batista MM; Azevedo R; Batista DDGJ; Soeiro MNC
Parasitology; 2024 Apr; 151(5):506-513. PubMed ID: 38533610
[No Abstract] [Full Text] [Related]
17. Furan derivatives impair proliferation and affect ultrastructural organization of Trypanosoma cruzi and Leishmania amazonensis.
Zuma AA; Teixeira de Macedo-Silva S; Achari A; Vinayagam J; Bhattacharjee P; Chatterjee S; Gupta VK; Cristina de Sousa Leite A; Souza de Castro L; Jaisankar P; de Souza W
Exp Parasitol; 2021 May; 224():108100. PubMed ID: 33744229
[TBL] [Abstract][Full Text] [Related]
18. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
[TBL] [Abstract][Full Text] [Related]
20. The potent cell permeable calpain inhibitor MDL28170 affects the interaction of Leishmania amazonensis with macrophages and shows anti-amastigote activity.
Marinho FA; Sangenito LS; Oliveira SSC; De Arruda LB; D'Ávila-Levy CM; Santos ALS; Branquinha MH
Parasitol Int; 2017 Oct; 66(5):579-583. PubMed ID: 28663009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
